121
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

One-Year Survival for Developing Acute Kidney Injury in Adult Patients with AMI Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation

, , , , , , ORCID Icon, , , , , , , , & show all
Pages 4537-4548 | Received 10 Jul 2023, Accepted 13 Sep 2023, Published online: 05 Oct 2023

References

  • Takayama H, Truby L, Koekort M, et al. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant. 2013;32(1):106–111. doi:10.1016/j.healun.2012.10.005
  • Samsky MD, Morrow DA, Proudfoot AG, Hochman JS, Thiele H, Rao SV. Cardiogenic shock after acute myocardial infarction: a review. JAMA. 2021;326(18):1840–1850. doi:10.1001/jama.2021.18323
  • Schmidt M, Burrell A, Roberts L, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015;36(33):2246–2256. doi:10.1093/eurheartj/ehv194
  • Schmidt M, Bréchot N, Hariri S, et al. Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clin Infect Dis. 2012;55(12):1633–1641. doi:10.1093/cid/cis783
  • Sutter R, Tisljar K, Marsch S. Acute neurologic complications during extracorporeal membrane oxygenation: a systematic review. Crit Care Med. 2018;46(9):1506–1513. doi:10.1097/ccm.0000000000003223
  • Lorusso R, Gelsomino S, Parise O, et al. Neurologic injury in adults supported with veno-venous extracorporeal membrane oxygenation for respiratory failure: findings from the extracorporeal life support organization database. Crit Care Med. 2017;45(8):1389–1397. doi:10.1097/ccm.0000000000002502
  • Kilburn DJ, Shekar K, Fraser JF. The complex relationship of extracorporeal membrane oxygenation and acute kidney injury: causation or association? Biomed Res Int. 2016;2016:1094296. doi:10.1155/2016/1094296
  • Gu M, Mei XL, Zhao YN. A review on extracorporeal membrane oxygenation and kidney injury. J Biochem Mol Toxicol. 2021;35(3):e22679. doi:10.1002/jbt.22679
  • Kooiman J, Seth M, Nallamothu BK, Heung M, Humes D, Gurm HS. Association between acute kidney injury and in-hospital mortality in patients undergoing percutaneous coronary interventions. Circ Cardiovasc Interv. 2015;8(6):e002212. doi:10.1161/circinterventions.114.002212
  • Mitchell AM, Kline JA, Jones AE, Tumlin JA. Major adverse events one year after acute kidney injury after contrast-enhanced computed tomography. Ann Emerg Med. 2015;66(3):267–274.e264. doi:10.1016/j.annemergmed.2015.04.028
  • Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442–448. doi:10.1038/ki.2011.379
  • Sun Y-B, Tao Y, Yang M. Assessing the influence of acute kidney injury on the mortality in patients with acute myocardial infarction: a clinical trail. Ren Fail. 2018;40(1):75–84. doi:10.1080/0886022x.2017.1419969
  • Stevens PE. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830. doi:10.7326/0003-4819-158-11-201306040-00007
  • Mou Z, He J, Guan T, Chen L. Acute kidney injury during extracorporeal membrane oxygenation: VA ECMO versus VV ECMO. J Intensive Care Med. 2022;37(6):743–752. doi:10.1177/08850666211035323
  • Parikh CR, Coca SG, Wang Y, Masoudi FA, Krumholz HM. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med. 2008;168(9):987–995. doi:10.1001/archinte.168.9.987
  • Goldberg A, Hammerman H, Petcherski S, et al. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J. 2005;150(2):330–337. doi:10.1016/j.ahj.2004.09.055
  • Jose P, Skali H, Anavekar N, et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol. 2006;17(10):2886–2891. doi:10.1681/asn.2006010063
  • Cheng R, Hachamovitch R, Kittleson M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1866 adult patients. Ann Thorac Surg. 2014;97(2):610–616. doi:10.1016/j.athoracsur.2013.09.008
  • Askenazi DJ, Selewski DT, Paden ML, et al. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clin J Am Soc Nephrol. 2012;7(8):1328–1336. doi:10.2215/cjn.12731211
  • Lackermair K, Brunner S, Orban M, et al. Outcome of patients treated with extracorporeal life support in cardiogenic shock complicating acute myocardial infarction: 1-year result from the ECLS-shock study. Clin Res Cardiol. 2021;110(9):1412–1420. doi:10.1007/s00392-020-01778-8
  • Meng Z, Zhao Y, Zheng X, He Y. The relationship between AKI in patients with STEMI and short-term mortality: a propensity score matching analysis. Angiology. 2021;72(8):733–739. doi:10.1177/0003319721998567
  • Uchino S, Bellomo R, Bagshaw SM, Goldsmith D. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant. 2010;25(6):1833–1839. doi:10.1093/ndt/gfp624
  • Kaltsas E, Chalikias G, Tziakas D. The incidence and the prognostic impact of acute kidney injury in acute myocardial infarction patients: current preventive strategies. Cardiovasc Drugs Ther. 2018;32(1):81–98. doi:10.1007/s10557-017-6766-6
  • Abadeer AI, Kurlansky P, Chiuzan C, et al. Importance of stratifying acute kidney injury in cardiogenic shock resuscitated with mechanical circulatory support therapy. J Thorac Cardiovasc Surg. 2017;154(3):856–864.e854. doi:10.1016/j.jtcvs.2017.04.042
  • Ostermann M, Connor M, Kashani K. Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how? Curr Opin Crit Care. 2018;24(6):493–503. doi:10.1097/mcc.0000000000000559
  • Lee CC, Chen SW, Cheng YL, et al. The impact of CRRT modality in patients with AKI receiving ECMO: a nationwide registry study in Taiwan. J Crit Care. 2020;57:102–107. doi:10.1016/j.jcrc.2020.02.006
  • Alba AC, Foroutan F, Buchan TA, et al. Mortality in patients with cardiogenic shock supported with VA ECMO: a systematic review and meta-analysis evaluating the impact of etiology on 29,289 patients. J Heart Lung Transplant. 2021;40(4):260–268. doi:10.1016/j.healun.2021.01.009
  • Hong D, Choi KH, Cho YH, et al. Multidisciplinary team approach in acute myocardial infarction patients undergoing veno-arterial extracorporeal membrane oxygenation. Ann Intensive Care. 2020;10(1):83. doi:10.1186/s13613-020-00701-8
  • Basir MB, Pinto DS, Ziaeian B, et al. Mechanical circulatory support in acute myocardial infarction and cardiogenic shock: challenges and importance of randomized control trials. Catheter Cardiovasc Interv. 2021;98(7):1264–1274. doi:10.1002/ccd.29593
  • Parr CJ, Sharma R, Arora RC, Singal R, Hiebert B, Minhas K. Outcomes of extracorporeal membrane oxygenation support in the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2020;96(3):547–555. doi:10.1002/ccd.28492
  • Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006;333(7578):1091. doi:10.1136/bmj.38985.646481.55
  • Hannan EL, Farrell LS, Wechsler A, et al. The New York risk score for in-hospital and 30-day mortality for coronary artery bypass graft surgery. Ann Thorac Surg. 2013;95(1):46–52. doi:10.1016/j.athoracsur.2012.08.047
  • Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010;55(18):1923–1932. doi:10.1016/j.jacc.2010.02.005
  • Auer J, Verbrugge FH, Lamm G. Editor’s choice- what do small serum creatinine changes tell us about outcomes after acute myocardial infarction? Eur Heart J Acute Cardiovasc Care. 2018;7(8):739–742. doi:10.1177/2048872617728721
  • Schwarz B, Abdel-Wahab M, Robinson DR, Richardt G. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation. Med Klin Intensivmed Notfmed. 2016;111(8):715–722. doi:10.1007/s00063-015-0118-8
  • Takano AM, Iwata H, Miyosawa K, et al. Reduced number of platelets during intra-aortic balloon pumping counterpulsation predicts higher cardiovascular mortality after device removal in association with systemic inflammation. Int Heart J. 2020;61(1):89–95. doi:10.1536/ihj.19-349
  • Vanderschueren S, De Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med. 2000;28(6):1871–1876. doi:10.1097/00003246-200006000-00031
  • Guimbretière G, Anselmi A, Roisne A, et al. Prognostic impact of blood product transfusion in VA and VV ECMO. Perfusion. 2019;34(3):246–253. doi:10.1177/0267659118814690
  • Losito I, Conte E, Cataldi TR, Cioffi N, Megli FM, Palmisano F. The phospholipidomic signatures of human blood microparticles, platelets and platelet-derived microparticles: a comparative HILIC-ESI-MS investigation. Lipids. 2015;50(1):71–84. doi:10.1007/s11745-014-3975-7
  • Winnersbach P, Rossaint J, Buhl EM, et al. Platelet count reduction during in vitro membrane oxygenation affects platelet activation, neutrophil extracellular trap formation and clot stability, but does not prevent clotting. Perfusion. 2022;37(2):134–143. doi:10.1177/0267659121989231
  • De Luca G, Silverio A, Verdoia M, et al. Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: a collaborative, individual patient data meta-analysis of six registry-based studies. Eur J Intern Med. 2022;105:69–76. doi:10.1016/j.ejim.2022.08.021
  • Tokarek T, Dziewierz A, Malinowski KP, et al. Treatment delay and clinical outcomes in patients with ST-segment elevation myocardial infarction during the COVID-19 pandemic. J Clin Med. 2021;10(17). doi:10.3390/jcm10173920
  • Tokarek T, Dziewierz A, Plens K, Rakowski T, Dudek D, Siudak Z. Radial approach reduces mortality in patients with ST-segment elevation myocardial infarction and cardiogenic shock. Pol Arch Intern Med. 2021;131(5):421–428. doi:10.20452/pamw.15886
  • Zabojszcz M, Januszek R, Siudak Z, et al. Association between the mortality rate and operator volume in patients undergoing emergency or elective percutaneous coronary interventions. Kardiol Pol. 2020;78(2):138–146. doi:10.33963/kp.15123
  • Tokarek T, Dziewierz A, Plens K, et al. Percutaneous coronary intervention during on- and off-hours in patients with ST-segment elevation myocardial infarction. Hellenic J Cardiol. 2021;62(3):212–218. doi:10.1016/j.hjc.2021.01.011